轴抑制蛋白1(Axin1)缺失诱导的小鼠肝癌发生需要完整的β-连环蛋白但不依赖Notch级联
该研究在小鼠中通过CRISPR/Cas9敲除Axin1联合转座子表达c-Met构建肝癌模型,发现Axin1缺失与c-Met协同诱导肝癌,该过程依赖β-连环蛋白信号,而阻断Notch级联不影响肝癌发生。
要点
- AXIN1失活突变约见于10%的人肝细胞癌。
- c-MET激活与AXIN1突变在约3%-5%的人肝癌样本中同时出现。
- 肝细胞特异性敲除Ctnnb1完全阻止c-Met/sgAxin1诱导的小鼠肝癌发生。
核心结论
- Axin1缺失与c-Met协同诱导小鼠肝癌,该过程依赖β-连环蛋白信号但不依赖Notch级联。
研究设计与样本
- 研究通过CRISPR/Cas9在小鼠肝脏敲除Axin1(sgAxin1)联合转座子表达c-Met构建肝癌模型(c-Met/sgAxin1)。
- 研究在肝细胞特异性Ctnnb1缺失小鼠中表达c-Met/sgAxin1以观察肝癌发生。
- 研究通过表达显性负性RBP-J或敲除Notch2阻断Notch级联,观察对c-Met/sgAxin1驱动肝癌发生的影响。
主要发现
- c-MET激活与AXIN1突变在约3%-5%的人肝癌样本中同时出现。
- c-Met/sgAxin1诱导的小鼠肝癌中Wnt/β-连环蛋白和Notch信号均激活,但与c-Met/∆N90-β-连环蛋白小鼠相应病变相比,仅少数经典Wnt/β-连环蛋白靶基因被诱导。
- 在肝细胞特异性Ctnnb1缺失小鼠中表达c-Met/sgAxin1完全阻止了肝癌发生。
- 在AXIN1突变或缺失的人肝癌细胞系中,沉默β-连环蛋白强烈抑制细胞增殖。
- 表达显性负性RBP-J或敲除Notch2阻断Notch级联未显著影响c-Met/sgAxin1驱动的肝癌发生。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inactivating mutations of axis inhibition protein 1 (AXIN1), a negative regulator of the Wnt/β-Catenin cascade, are among the common genetic events in human hepatocellular carcinoma (HCC), affecting approximately 10% of cases. In the present manuscript, we sought to define the genetic crosstalk between Axin1 mutants and Wnt/β-catenin as well as Notch signaling cascades along hepatocarcinogenesis. We discovered that c-MET activation and AXIN1 mutations occur concomitantly in ~3%-5% of human HCC samples. Subsequently, we generated a murine HCC model by means of CRISPR/Cas9-based gene deletion of Axin1 (sgAxin1) in combination with transposon-based expression of c-Met in the mouse liver (c-Met/sgAxin1). Global gene expression analysis of mouse normal liver, HCCs induced by c-Met/sgAxin1, and HCCs induced by c-Met/∆N90-β-Catenin revealed activation of the Wnt/β-Catenin and Notch signaling in c-Met/sgAxin1 HCCs. However, only a few of the canonical Wnt/β-Catenin target genes were induced in c-Met/sgAxin1 HCC when compared with corresponding lesions from c-Met/∆N90-β-Catenin mice. To study whether endogenous β-Catenin is required for c-Met/sgAxin1-driven HCC development, we expressed c-Met/sgAxin1 in liver-specific Ctnnb1 null mice, which completely prevented HCC development. Consistently, in AXIN1 mutant or null human HCC cell lines, silencing of β-Catenin strongly inhibited cell proliferation. In striking contrast, blocking the Notch cascade through expression of either the dominant negative form of the recombinant signal-binding protein for immunoglobulin kappa J region (RBP-J) or the ablation of Notch2 did not significantly affect c-Met/sgAxin1-driven hepatocarcinogenesis. Conclusion: We demonstrated here that loss of Axin1 cooperates with c-Met to induce HCC in mice, in a β-Catenin signaling-dependent but Notch cascade-independent way.
引用
- Qiao Y, Wang J, Karagoz E, et al. Axis inhibition protein 1 (Axin1) Deletion-Induced Hepatocarcinogenesis Requires Intact β-Catenin but Not Notch Cascade in Mice. Hepatology. 2019. PMID: 30737831. doi:10.1002/hep.30556
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。